Marbonor

1 x 100 ml

Liquid for injection, solution

Active substance

Marbofloxacin : 100 mg/ml

ATC code

QJ01MA93 Marbofloxacin

QJ01MA Fluoroquinolones

QJ01M Quinolone and quinoxaline antibacterials

QJ01 Antibacterials for systemic use

QJ Antiinfectives for systemic use

Species

Cattle and Pigs (sows)

Indications

Cattle

Treatment of respiratory infections caused by susceptible strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma bovis. Treatment of acute mastitis caused by Escherichia coli strains susceptible to marbofloxacin during the lactation period.

Sows

Treatment of Metritis Mastitis Agalactia Syndrome (postpartum dysgalactia syndrome, PDS) caused by bacterial strains susceptible to marbofloxacin.

Dose to be administered and administration route

To ensure administration of a correct dose, bodyweight should be determined as accurately as possible to avoid underdosing.

The recommended dosage is 2 mg marbofloxacin/kg bodyweight (1 ml of the product/50 kg bodyweight) in a single daily injection by intramuscular, subcutaneous or intravenous routes in cattle and by intramuscular route in pigs. For the injections, the neck should be preferred in cattle and pigs

Treatment durations are 3 days in pigs and 3 to 5 days in cattle.

The vial may be broached up to 35 times. The user should choose the most appropriate vial size according to the target species to be treated.

Adverse reactions

Administration by the intramuscular route may cause transient local reactions such as pain and swelling at the injection site and inflammatory lesions which may persist for at least 12 days after injection. However, in cattle the subcutaneous route was shown to be better tolerated locally than the intramuscular route. Therefore, the subcutaneous route is recommended in heavy cattle.